Rural Environment as a Risk Factor for the Age at Onset of Machado-Joseph Disease

被引:0
|
作者
Martins, Ana Carolina [1 ,2 ]
Furtado, Gabriel Vasata [2 ]
Pinheiro, Jordania Dos Santos [2 ,3 ]
Saraiva-Pereira, Maria Luiza [1 ,2 ,4 ,5 ]
Jardim, Laura Bannach [1 ,2 ,4 ,6 ]
机构
[1] Univ Fed Rio Grande do Sul, Programa Posgrad Genet & Biol Mol, Porto Alegre, Brazil
[2] Hosp Clin Porto Alegre, Ctr Pesquisa Clin & Expt, Porto Alegre, Brazil
[3] Univ Fed Rio Grande do Sul, Fac Farm, Porto Alegre, Brazil
[4] Hosp Clin Porto Alegre, Med Genet Serv, Rua Ramiro Barcelos 2350, BR-90035003 Porto Alegre, Brazil
[5] Univ Fed Rio Grande do Sul, Dept Bioquim, Porto Alegre, Brazil
[6] Univ Fed Rio Grande do Sul, Dept Med Interna, Porto Alegre, Brazil
来源
MOVEMENT DISORDERS CLINICAL PRACTICE | 2025年
关键词
Machado-Joseph disease; rural environment; demographic density; rural population; untreated well water; AMYOTROPHIC-LATERAL-SCLEROSIS;
D O I
10.1002/mdc3.14338
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Machado-Joseph disease (SCA3/MJD) is a neurodegenerative condition caused by a dominant expansion of a CAG repeat (CAGexp). Most of the variability in the age at onset of symptoms (AO) remains unexplained, and environmental influences were scarcely studied. Objective: The objective was to test if AO of SCA3/MJD carriers can be associated with markers of the rural environment, such as demographic density (DeD), proportion of rural population (PRP), and the consumption of untreated well water (CWW). Methods: Symptomatic subjects from Rio Grande do Sul, Brazil, diagnosed between 1999 and 2017, and living in the same municipalities where they were born, were included, provided their CAGexp and AO were available, and the residual AO (RAO) could be estimated. DeD, PRP, and CWW were obtained from the Brazilian Census of 2010. Participants were stratified in high versus low DeD, PRP, and CWW groups, and their RAOs were compared for a P < 0.05. Results: A total of 188 subjects were studied. The mean (SD) RAOs of subjects from low and high DeD groups were -1.90 (6.98) and -0.11 (6.20) (P = 0.046); from low and high PRP groups were -0.12 (6.20) and -1.90 (6.99) (P = 0.046); and from low and high CWW groups were -0.11 (6.04) and -1.89 (7.11) (P = 0.034). Conclusions: AO of SCA3/MJD carriers was earlier in groups related to rural life. Our evidence suggests the presence of a risk factor in the rural environment, for earlier onset of symptoms in SCA3/MJD.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Nonmotor and extracerebellar features in Machado-Joseph disease: A review
    Pedroso, Jose Luiz
    Franca, Marcondes C., Jr.
    Braga-Neto, Pedro
    D'Abreu, Anelyssa
    Saraiva-Pereira, Maria Luiza
    Saute, Jonas A.
    Teive, Helio A.
    Caramelli, Paulo
    Jardim, Laura Bannach
    Lopes-Cendes, Iscia
    Barsottini, Orlando Graziani P.
    MOVEMENT DISORDERS, 2013, 28 (09) : 1200 - 1208
  • [22] Dopaminergic response in Parkinsonian phenotype of Machado-Joseph disease
    Buhmann, C
    Bussopulos, A
    Oechsner, M
    MOVEMENT DISORDERS, 2003, 18 (02) : 219 - 221
  • [23] Planning Future Clinical Trials for Machado-Joseph Disease
    Morales Saute, Jonas Alex
    Jardim, Laura Bannach
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 321 - 348
  • [24] Cerebellar Rotation Abnormalities Observed in Machado-Joseph Disease
    Nomura, Taichi
    Iwata, Ikuko
    Harada, Taisuke
    Yabe, Ichiro
    INTERNAL MEDICINE, 2020, 59 (24) : 3253 - 3254
  • [25] 3. Clinical Features of Machado-Joseph Disease
    Mendonca, Nuno
    Franca, Marcondes C., Jr.
    Goncalves, Antonio Freire
    Januario, Cristina
    POLYGLUTAMINE DISORDERS, 2018, 1049 : 255 - 273
  • [26] Trehalose in Machado-Joseph Disease: Safety, Tolerability, and Efficacy
    Roy Zaltzman
    Zohar Elyoseph
    Nirit Lev
    Carlos R. Gordon
    The Cerebellum, 2020, 19 : 672 - 679
  • [27] Profiling Microglia in a Mouse Model of Machado-Joseph Disease
    Campos, Ana Bela
    Duarte-Silva, Sara
    Fernandes, Bruno
    das Neves, Sofia Pereira
    Marques, Fernanda
    Teixeira-Castro, Andreia
    Neves-Carvalho, Andreia
    Monteiro-Fernandes, Daniela
    Portugal, Camila Cabral
    Socodato, Renato
    Summavielle, Teresa
    Ambrosio, Antonio Francisco
    Relvas, Joao Bettencourt
    Maciel, Patricia
    BIOMEDICINES, 2022, 10 (02)
  • [28] Brainstem in Machado-Joseph disease: atrophy or small size?
    Horimoto, Y.
    Matsumoto, M.
    Yuasa, H.
    Kojima, A.
    Nokura, K.
    Katada, E.
    Yamamoto, T.
    Yamamoto, H.
    Mitake, S.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (01) : 102 - 105
  • [29] Sleep symptoms and their clinical correlates in Machado-Joseph disease
    D'Abreu, A.
    Franca, M., Jr.
    Conz, L.
    Friedman, J. H.
    Nucci, A. M.
    Cendes, F.
    Lopes-Cendes, I.
    ACTA NEUROLOGICA SCANDINAVICA, 2009, 119 (04): : 277 - 280
  • [30] Decreased benzodiazepine receptor binding in Machado-Joseph disease
    Ishibashi, M
    Sakai, T
    Matsuishi, T
    Yonekura, Y
    Yamashita, Y
    Abe, T
    Ohnishi, Y
    Hayabuchi, N
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (09) : 1518 - 1520